Accuray CEO resigns after a decade

Editorial Staff | | Health Imaging | Oncology Imaging

Accuray's President, CEO and Director of the Board, Euan S. Thomson, has resigned. Accuray's Board has appointed Joshua H. Levine as his successor as president, CEO and director of the board, effective immediately. Thomson is anticipated to continue in a consulting role with the company.

Thomson joined Accuray in March 2002 as CEO, was appointed president in September 2002 and served on the board of directors. During his tenure, Thomson expanded the radiosurgery market with the company's product, the CyberKnife System. He took the company public in February 2007 and led the company through the acquisition of TomoTherapy in 2011. Sunnyvale-based Accuray said the addition of the TomoTherapy system to the its product portfolio expanded the company into the radiation therapy market.

Levine was CEO of Mentor where he was instrumental in its sale to a franchise of Johnson & Johnson in January 2009, and more recently was CEO of Immucor until October 2011, when it was acquired by TPG Capital.

Editorial Staff

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.